Optimising your Business Potential with Major Pharma

A significant area of our activity is focused on supporting pharma service organisations (CROs, CDMOs, technology providers) in fine-tuning and improving their ability to attract, retain and grow business with pharmaceutical clients.  We provide high-impact advice to senior CDMO decision makers globally, addressing challenges in three key areas:

  • Sales Optimisation: from the initial RFP response through to high performance partnering with Pharma customers.
    • Review of Business Development package
    • Simulated pitch and/or supplier selection
    • Review of client proposals
  • Diagnosis and fine-tuning of key internal enablers:
    • Capabilities analysis
    • Customer responsiveness
    • Talent management
  • Validation of growth, expansion or M&A opportunities:  particularly those lying outside current core areas of capability.

Chemical Process R&D and Industrialisation

Berzelius offers scientific and technical consultancy support for all chemical process R&D and industrialisation activities.  We are also active in supporting pharma companies in developing API strategy in the overall CMC context, extending beyond the scientific and technical dimension to benchmarking and selection of potential partners.  Key service areas include:

  • Scientific and technical support: for API projects at all development phases.
    • Route selection and process R&D
    • Support for filing, launch and post-launch activities
    • Second generation process development
    • Process optimisation and troubleshooting
  • Building internal capability through organic growth:
    • Formulation of recruitment strategy
    • Support for hiring activities
    • Technology strategy & investment planning
  • External strategy development and implementation:
    • Development of external partnering strategy
    • Selection of PR&D and manufacturing partners
    • Initiation & oversight of API outsourcing activity
    • Establishing technology partnerships

Your Growth through Mergers and Acquisitions

Berzelius is able to draw on long experience of M&A and L&A activity in the pharmaceutical and fine chemicals space, including the technical evaluation of product licensing and co-development opportunities. Our areas of activity range from initial analysis and technical evaluation through to post-Day 1 activities, including:

  • Due diligence support:
    • Technology capability assessment
    • Plant and process-related assessments
    • External partner and CDMO evaluation
  • Integration & onboarding:
    • Formulating and validating strategic direction
    • Organisational design
    • Talent management and hiring support
    • Development of competency models



Our approach to client assignments

Customer-focused and customised interventions are core to our offering, being differentiated by our drive to understand and address complex scenarios with simplicity and clarity.  Our intent is also to provide a high impact and hands-on service, fully respecting client confidentiality and in close partnership with our clients, characterised by:

  • Focused and time-limited approach to assignments
  • Clear analysis and understanding of issues and root causes
  • Development of integrated solutions and options
  • Adapting to meet evolving project needs
  • Clearly stated expectations and deliverables
  • Transparent and open communication

Next Steps...

Our aim is always to support our clients in addressing their challenges in an increasingly complex industry environment.  We would be pleased to discuss your specific situation and requirements with you, in order to work with you in providing a structured way forward.

Logo Berzelius Ltd